{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:09:08Z","timestamp":1783904948987,"version":"3.55.0"},"reference-count":15,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammatory bowel diseases are autoimmune disorders affecting the gastrointestinal tract and producing a wide variety of extraintestinal manifestations. Kidneys are a rare target organ of their extraintestinal activity, but if affected, renal function could deteriorate to end-stage kidney disease, which is curable only by organ transplantation. Renal calculi are the most common pathological kidney manifestation in IBD patients, followed by tubulointerstitial nephritis, glomerulonephritis, and other kidney pathologies.<\/jats:p>\n                  <jats:p>The liver is the most commonly transplanted organ in IBD patients (primary sclerosing cholangitis and autoimmune hepatitis), and a scarcity of literature on kidney recipients is present to date regarding the incidence of renal insufficiency, kidney transplantations, post-transplant IBD course and further complications such as graft rejection or infections in this specific group of patients. De novo IBD is a paradoxical entity in the setting of rigorous post-transplant immunosuppression.<\/jats:p>\n                  <jats:p>In this case series, we present three patients who underwent kidney transplantation with a history of an IBD and one patient who developed de novo Crohn\u2019s disease after the deceased donor organ transplant was performed.<\/jats:p>","DOI":"10.2478\/prilozi-2022-0006","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T03:41:11Z","timestamp":1650598871000},"page":"57-63","source":"Crossref","is-referenced-by-count":1,"title":["Inflammatory Bowel Diseases in Renal Transplantat Recipients: A Case Series and Review of the Literature"],"prefix":"10.2478","volume":"43","author":[{"given":"Jakob","family":"Vrus","sequence":"first","affiliation":[{"name":"Medical Centre \u010cakovec"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolina Ba\u0161i\u0107","family":"Juki\u0107","sequence":"additional","affiliation":[{"name":"School of medicine Zagreb , University of Zagreb, School of medicine, University J.J. Strossmayer, Osijek , and Department of nephrology, arterial hypertension, dialysis and transplantation , University Hospital Centre Zagreb , Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,4,22]]},"reference":[{"key":"2026071214253952818_j_prilozi-2022-0006_ref_001","doi-asserted-by":"crossref","unstructured":"1. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021 Jun 3; 384(22): 2092\u20132101. doi: 10.1056\/NEJMoa2104840. Epub 2021 Apr 9. PMID: 33835769; PMCID: PMC8095372.10.1056\/NEJMoa2104840809537233835769","DOI":"10.1056\/NEJMoa2104840"},{"key":"2026071214253952818_j_prilozi-2022-0006_ref_002","doi-asserted-by":"crossref","unstructured":"2. Bosevski M, Mitevska I, Pavkovic M, Klincheva M, Lazarova ET, Velkova E, Stojanoski Z, Kostova N, Jordanova SP, Petkoska D, Mancheva M, Gulevska A, Baloski M, Hadjiev V, Krstevski G, Kralevska V, Bojovski I, Jovanovski M, Nedelkovska V, Gjorgievski A. Special Conditions in Venous Thromboembolism \u2013 Case Series. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Oct 1; 40(2): 103\u2013111. doi: 10.2478\/prilozi-2019-0021. PMID: 31605581.10.2478\/prilozi-2019-002131605581","DOI":"10.2478\/prilozi-2019-0021"},{"key":"#cr-split#-2026071214253952818_j_prilozi-2022-0006_ref_003.1","doi-asserted-by":"crossref","unstructured":"3. Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, Rampotas A, Ambler G, Makris M. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis. N Engl J Med. 2021 Oct 28","DOI":"10.1056\/NEJMoa2109908"},{"key":"#cr-split#-2026071214253952818_j_prilozi-2022-0006_ref_003.2","doi-asserted-by":"crossref","unstructured":"385(18): 1680-1689. doi: 10.1056\/NEJMoa2109908. Epub 2021 Aug 11. PMID: 34379914.","DOI":"10.1056\/NEJMoa2109908"},{"key":"2026071214253952818_j_prilozi-2022-0006_ref_004","doi-asserted-by":"crossref","unstructured":"4. Scully M, Singh D, Lown R, Poles A, Solomon T, Levi M, Goldblatt D, Kotoucek P, Thomas W, Lester W. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021 Jun 10; 384(23): 2202\u20132211. doi: 10.1056\/NEJMoa2105385. Epub 2021 Apr 16. PMID: 33861525; PMCID: PMC8112532.10.1056\/NEJMoa2105385811253233861525","DOI":"10.1056\/NEJMoa2105385"},{"key":"2026071214253952818_j_prilozi-2022-0006_ref_005","doi-asserted-by":"crossref","unstructured":"5. Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine. 2021 Sep;39:101061. doi: 10.1016\/j.eclinm.2021.101061. Epub 2021 Jul 31. PMID: 34368663; PMCID: PMC8324974.10.1016\/j.eclinm.2021.101061832497434368663","DOI":"10.1016\/j.eclinm.2021.101061"},{"key":"#cr-split#-2026071214253952818_j_prilozi-2022-0006_ref_006.1","doi-asserted-by":"crossref","unstructured":"6. Chen VM, Curnow JL, Tran HA, Choi PY. Australian and New Zealand approach to diagnosis and management of vaccine-induced immune thrombosis and thrombocytopenia. Med J Aust. 2021 Sep 20","DOI":"10.5694\/mja2.51229"},{"key":"#cr-split#-2026071214253952818_j_prilozi-2022-0006_ref_006.2","unstructured":"215(6): 245-249.e1. doi: 10.5694\/mja2.51229. Epub 2021 Sep 6. Erratum in: Med J Aust. 2021 Oct 22;: PMID: 34490632."},{"key":"2026071214253952818_j_prilozi-2022-0006_ref_007","doi-asserted-by":"crossref","unstructured":"7. Cines DB, Bussel JB. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021 Jun 10; 384(23): 2254\u20132256. doi: 10.1056\/NEJMe2106315. Epub 2021 Apr 16. Erratum in: N Engl J Med. 2021 Jun 10; 384(23):e92. PMID: 33861524; PMCID: PMC8063912.10.1056\/NEJMe2106315806391233861524","DOI":"10.1056\/NEJMe2106315"},{"key":"2026071214253952818_j_prilozi-2022-0006_ref_008","doi-asserted-by":"crossref","unstructured":"8. Hippisley-Cox J, Patone M, Mei XW, Saatci D, Dixon S, Khunti K, Zaccardi F, Watkinson P, Shankar-Hari M, Doidge J, Harrison DA, Griffin SJ, Sheikh A, Coupland CAC. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ. 2021 Aug 26; 374: n1931. doi: 10.1136\/bmj.n1931. PMID: 34446426; PMCID: PMC8388189.10.1136\/bmj.n1931838818934446426","DOI":"10.1136\/bmj.n1931"},{"key":"2026071214253952818_j_prilozi-2022-0006_ref_009","doi-asserted-by":"crossref","unstructured":"9. Thaler J, Ay C, Gleixner KV, Hauswirth AW, Cacioppo F, Grafeneder J, Quehenberger P, Pabinger I, Kn\u00f6bl P. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). J Thromb Haemost. 2021 Jul; 19(7): 1819\u20131822. doi: 10.1111\/jth.15346. Epub 2021 Jun 11. PMID: 33877735; PMCID: PMC8362082.10.1111\/jth.15346836208233877735","DOI":"10.1111\/jth.15346"},{"key":"2026071214253952818_j_prilozi-2022-0006_ref_010","doi-asserted-by":"crossref","unstructured":"10. Elalamy I, Gerotziafas G, Alamowitch S, Laroche JP, Van Dreden P, Ageno W, Beyer-Westendorf J, Cohen AT, Jimenez D, Brenner B, Middeldorp S, Cacoub P; Scientific Reviewer Committee. SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia. Thromb Haemost. 2021 Aug; 121(8): 982\u2013991. doi: 10.1055\/a-1499-0119. Epub 2021 May 4. PMID: 33946120; PMCID: PMC8322589.10.1055\/a-1499-0119832258933946120","DOI":"10.1055\/a-1499-0119"},{"key":"#cr-split#-2026071214253952818_j_prilozi-2022-0006_ref_011.1","doi-asserted-by":"crossref","unstructured":"11. Tsang HF, Chan LWC, Cho WCS, Yu ACS, Yim AKY, Chan AKC, Ng LPW, Wong YKE, Pei XM, Li MJW, Wong SC. An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies. Expert Rev Anti Infect Ther. 2021 Jul","DOI":"10.1080\/14787210.2021.1863146"},{"key":"#cr-split#-2026071214253952818_j_prilozi-2022-0006_ref_011.2","doi-asserted-by":"crossref","unstructured":"19(7): 877-888. doi: 10.1080\/14787210.2021.1863146. Epub 2020 Dec 29. PMID: 33306423.","DOI":"10.1080\/14787210.2021.1863146"},{"key":"2026071214253952818_j_prilozi-2022-0006_ref_012","doi-asserted-by":"crossref","unstructured":"12. Vercruysse K, Devreese KMJ. Laboratory testing for post ChAdOx1 nCOV-19 vaccination VITT: A challenge. Comment on: Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost. 2021 Sep; 19(9): 2355\u20132357. doi: 10.1111\/jth.15457. Epub 2021 Jul 27. PMID: 34312992; PMCID: PMC8420275.10.1111\/jth.15457842027534312992","DOI":"10.1111\/jth.15457"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2022-0006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:30:22Z","timestamp":1783902622000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2022-0006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,4,22]]},"published-print":{"date-parts":[[2022,3,1]]}},"alternative-id":["10.2478\/prilozi-2022-0006"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2022-0006","relation":{},"ISSN":["1857-8985"],"issn-type":[{"value":"1857-8985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}